Literature DB >> 24319616

Vibrio cholerae antimicrobial drug resistance, Papua New Guinea, 2009-2011.

Manoj Murhekar1, Samir Dutta, Berry Ropa, Rosheila Dagina, Enoch Posanai, Alexander Rosewell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24319616      PMCID： PMC3854095          DOI： 10.5365/WPSAR.2013.4.2.002

Source DB:  PubMed          Journal:  Western Pac Surveill Response J        ISSN： 2094-7321


× No keyword cloud information.
  10 in total

1.  Antibiotics for both moderate and severe cholera.

Authors:  Eric J Nelson; Danielle S Nelson; Mohammed A Salam; David A Sack
Journal:  N Engl J Med       Date:  2010-12-09       Impact factor: 91.245

2.  Meeting of the Strategic Advisory Group of Experts on immunization, October 2009 - conclusions and recommendations.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2009-12-11

3.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

4.  Global surveillance of antibiotic sensitivity of Vibrio cholerae.

Authors:  F O'Grady; M J Lewis; N J Pearson
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

5.  Single-dose azithromycin for the treatment of cholera in adults.

Authors:  Debasish Saha; Mohammad M Karim; Wasif A Khan; Sabeena Ahmed; Mohammed A Salam; Michael L Bennish
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

6.  Antibiotic therapy of cholera.

Authors:  J Lindenbaum; W B Greenough; M R Islam
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

7.  Effects of doxycycline in actively purging cholera patients: a double-blind clinical trial.

Authors:  M M Rahaman; M A Majid; M R Islam
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

Review 8.  Cholera.

Authors:  David A Sack; R Bradley Sack; G Balakrish Nair; A K Siddique
Journal:  Lancet       Date:  2004-01-17       Impact factor: 79.321

9.  Vibrio cholerae O1 in 2 coastal villages, Papua New Guinea.

Authors:  Alexander Rosewell; Rosheila Dagina; Manoj Murhekar; Berry Ropa; Enoch Posanai; Samir R Dutta; Amy Jennison; Helen Smith; Glen Mola; Anthony Zwi; C Raina MacIntyre
Journal:  Emerg Infect Dis       Date:  2011-01       Impact factor: 6.883

10.  Clonal origins of Vibrio cholerae O1 El Tor strains, Papua New Guinea, 2009-2011.

Authors:  Paul F Horwood; Deirdre Collins; Marinjho H Jonduo; Alexander Rosewell; Samir R Dutta; Rosheila Dagina; Berry Ropa; Peter M Siba; Andrew R Greenhill
Journal:  Emerg Infect Dis       Date:  2011-11       Impact factor: 6.883
  10 in total
  2 in total

1.  Geographical distribution and antibiotics susceptibility patterns of toxigenic Vibrio cholerae isolates from Kisumu County, Kenya.

Authors:  Silas O Awuor; Eric O Omwenga; Ibrahim I Daud
Journal:  Afr J Prim Health Care Fam Med       Date:  2020-12-08

2.  Global status of tetracycline resistance among clinical isolates of Vibrio cholerae: a systematic review and meta-analysis.

Authors:  Mohammad Hossein Ahmadi
Journal:  Antimicrob Resist Infect Control       Date:  2021-08-06       Impact factor: 4.887
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.